European Journal of Medicine and Natural SciencesVol. 8 No. 3 (2025)

European Journal of Medicine and Natural Sciences

Volume 8, Issue 3, 2025 · ISSN 2601-6397 (Print) · ISSN 2601-6400 (Online)

Therapeutical Properties of Bioactive Compounds Extracted from Ganoderma lucidum Species on Acute and Chronic Diseases

Carolina Pascale1*, Rodica Sirbu1, Emin Cadar2

1University of Medicine and Pharmacy Carol Davila, Bucharest, Romania; 2Ovidius University of Constanta, Faculty of Pharmacy, Romania

*pascale.carolina@yahoo.ro

Submitted: 2025-08-28 · Accepted after Revision: 2025-11-28 · Published: 2025-12-28

DOI: 10.2478/ejnsm-2023-0008

Abstract

Ganoderma lucidum or Reishi is a medicinal mushroom of significant importance that is being used for the prevention and treatment of various diseases, due to its numerous pharmacological and therapeutic properties. The Ganodermataceae family is diverse, but the focus is on the lucidum species because of its specific biologically active macromolecules such as polysaccharides, triterpenoids, steroids, phenolic compounds, lactones, and fatty acids that were isolated from the mycelia and fruiting bodies. Ganoderma lucidum species have many benefits over the immune system (promoting health) and properties such as: anti-tumoral, anti-inflammatory, anti-allergic, anti-viral, anti-bacterial and antioxidant. Based on the literature, triterpenoids and polysaccharides are the most abundant active compounds that possess anti-diabetic, hepatoprotective, cytotoxic and anti-hypertensive effects. A review of the literature showed that there are very few papers that studied semisolid dosage forms preparations based of Ganoderma lucidum extract to have been used on damaged skin and skin diseases, neither have there been enough studies on its anti-aging properties.

Keywords: Ganoderma lucidum, polysaccharides, anti-inflammatory, anti-tumoral, antioxidant

Introduction

Currently, medicine based on plant extracts or other medicinal herbs is in great demand by the population, since most are looking for a way to live healthy or looking for alternative medicine based on herbal extracts. Still, fungus extracts are in great demand, especially those from Ganodermataceae family due to its promotions over the years, which shows through statements and studies that is still a wonder-mushroom [1]. It is known that medicinal mushrooms have been used in over the years to treat many disorders, for promoting health and longevity in Asian countries. Among Eastern population, the name Reishi or Mannentake is commonly used by Japanese people and is the symbol of good health. In Chinese and Korea, it is known as LingZhi and represents a combination of spiritual potency and essence of immortality [2]. Ganoderma lucidum (G. lucidum) also known as Reishi and LingZhi, is the most known medicinal macrofungal species, with a long history in promoting health in different countries, especially in China and Japan. The medicinal activity of G. lucidum fungus is localized, for example, inhibiting the activity of the enzyme cyclooxygenase in the anti-inflammatory response [3] and proliferation of the immune system by inhibiting its activity in cases of overstimulation [4].

Various formulations and products based on this fungus species are now available on the market. These are extracted from different parts of the fungus: mycelium, spores, and fruiting body. Most products are in the form of tea, tonics and coffee, powders, and encapsulated food supplements [4].

Botanical Description

G. lucidum is a kidney-shaped mushroom [4] with glossy surface and woody texture [5]. Ganoderma genus can be found all over the world, mainly in tropical and subtropical climates [6], but different characteristics of the fruiting body, soil specificity and geographical origin are used to identify individual species of this medicinal fungus. The Ganodermataceae family consists of many fungi from the Ganoderma genus [6] and the taxonomy classification of this species is related into Table 1.

This species grows on multiple hosts, on living trees or stumps of oak and is growing rarely on coniferous trees [2]. In Europe, specially in Romania, it can be found in the Sub Carpati mountain chain region. The medicinal mushroom, Ganoderma lucidum, taken in work, weighs 0.25 grams, is 9-10 cm wide and 9-10 cm long and is quite bulky, has a dark reddish shiny surface and a woody texture, see Fig. 1.

Kingdom Fungi
Phylum Basidiomycota
Class Basidiomycetes
Sub-class Homobasidiomycetes
Family Ganodermataceae
Genus Ganoderma
Species lucidum
Figure 1

Fig. 1 Ganoderma lucidum (personal archive)

Polysacharides and Triterpenes of Ganoderma Lucidum Extract

Polysaccharides and triterpenes are the most abundant biocomponents in the composition of G. lucidum [1]. The most important functions of polysaccharides are reported by numerous studies, and there are: normalizing blood glucose levels, restoring the enzymatic balance in the intestinal tract due to the probiotic effect [8], reducing damage through antioxidant effect on free radicals formed in oxidation reactions. Anti-diabetic and anti-tumor effects have also been reported for both the polysaccharide and triterpenoid components [9]. In addition to these effects, triterpenoids have an immunomodulatory effect, proven by in vivo and in vitro studies. Beside these two major bioactive compounds, the mushroom contains in significant quantities proteins, lipids, carbohydrates and sodium chloride [10].

Triderpenoids from the G. Lucidum Mushroom

There are many types of triterpenoid compounds that have been isolated from the G. lucidum mushroom, the most common are ganodermic, lucidenic, ganoderals, ganoderols and applanoxidic acids. The most characteristic acids in the composition are ganodermic acid F (Fig. 2), lucidenic acid D1 (Fig. 3), ganoderal A (Fig. 4), ganoderol B (Fig. 5) and applanoxidic acid A (Fig. 6) [9].

Figure 2

Fig. 2 Ganodermic acid F

Figure 3

Fig. 3 Lucidenic acid D1

Figure 4

Fig. 4 Ganoderal A

Figure 5

Fig. 5 Ganoderol B

Figure 6

Fig. 6 Applanoxidic acid A

Polysaccharides from the G. Lucidum Species

Polysaccharides are important elements in both the pharmaceutical and food industries, due to their ability to defend the body against pathogens through various mechanisms [11]. These compounds are able to interact with the immune system and to enhance mechanisms of response. Its structure is composed of long-chain sugar molecules linked together by glycosidic bonds. Numerous types of them have been isolated in the Ganoderma species. Polysaccharides from this mushroom have heteropolymers with high molecular wight where the major components are glucose, mannose, galactose, and fructose. [12, 13]. Fig. 7 represents the side-chain of β-glucan with protein in polysaccharide-K [14].

Figure 7

Fig. 7 β-glucan side-chain

Therapeutical Applications

Ganoderma lucidum is known to have a very wide range of pharmacological effects. Among these, we list the immuno-modulatory, hypocholesterolaemia, anti-inflammatory and analgesic, antitumor, antibacterial, antiviral, and antifungal, hepatoprotective, antidiabetic, antioxidant effects [5, 12, 15-17]. Today, it is used by a very large number of people especially as an adjuvant medication in the treatment of cancer, hepatitis, diabetes and for anti-aging property [12, 8]. Fig. 8 represents pharmacological actions of both compounds, polysaccharides and triterpenoids.

Figure 8

Fig. 8 Ganoderma lucidum pharmacological effects

Anti-Inflammatory Properties

The anti-inflammatory action is achieved by inhibiting the activity of cyclooxygenase enzymes, which are responsible for the production of prostaglandins. A study related by Joseph et al. [3] showed that the chloroform extract of G. lucidum has huge inhibitory potential of the inflammation induced by carrageenan and formalin, in the mice paws. The chloroform extract showed a 73,4% reduction at a concentration of 100mg/kg body weight, and a 63,2% reduction of inflammation at a concentration of 50mg/kg body weight of chloroform extract from the G. lucidum for carrageenan-induced inflammation. A reduction in inflammation of 63,4% and 53,4% for the same concentrations was observed in formalin-induced inflammation in the oedematous paw of the mice. For the standard reference, the study used the anti-inflammatory drug diclofenac, which showed an inhibition of oedemas of 53,0% and 40,2% for the same concentrations [3].

Anti-Tumoral Activity

The anti-tumoral effect of different G. lucidum extracts has been intensively studied by several groups of researchers. A study showed that the ethanolic extract of G. lucidum, which contains a high number of phenolic compounds, indicates antiproliferative activity in human cervical carcinoma, human alveolar basal adenocarcinoma, and human colon carcinoma [19]. Following the analysis, the author related an important correlation between the antiproliferative activity against human cervical carcinoma and the total phenolic compounds, and antiproliferative activity against human alveolar basal adenocarcinoma and total glucans content. The most abundant phenolic compounds were hesperetin and naringenin, for each analysed sample of the study [19]. In another study, an important part of the antiproliferative activity against cancer cell line is attributed to the high content of total phenolic compounds such as resveratrol and apigenin. Quantitative analysis of the total polyphenolic compounds showed that from 13,991.10 mg of total polyphenolic compounds per 100g of the extract, resveratrol was the most abundant with 5155,70 mg and apigenin with 4039.08 mg [20].

The clinical potential and a wide acceptance of extracts obtained from G. lucidum in terms of its antitumoral activity as an alternative therapy have developed interest in the research of its molecular mechanisms. [21]. In table 2 and 3 are related applications, activities, and mechanism of action of different G. lucidum extracts and for purified Ganoderic acids on multiple types of cancer cells.

Tabel 2 G. lucidum extracts- applications, activities and mechanism of action

Ganoderma lucidum extracts Antitumoral applications Mechanism of action References
Dried powder of G. lucidum dissolved in boiled water

Invasive breast cancer

Prostate cancer

Produces down-regulation of transcription factors AP-1 and NF-κB in cancer cells. [22]
Hot water extraction Drug-sensitive (H69) and multi-drug resistant (VPA) human SCLC (small-cell lung cancer) cells. Both cells show equal cytotoxicity [23]
Ethanolic extract of G. lucidum Human Urothelial cells (bladder cancer) In vitro – ethanolic extract exhibits a potent inhibition and induces growth arrest and cell migration [24]
Methanolic extract Inhibit several cancer cell lines including hematological cell lines (lymphomas and multiple myelomas)

Upregulation of p21/p27

Induction of cell line arrest

[25]

Tabel 3 Subtypes of Ganoderic Acids- applications, activities and machanism of action

Subtypes of Ganoderic Acids Antitumoral applications Mechanism of action References
Ganoderic Acid X (GA-X)

Hepatoma cells

Colorectal carcinoma

Acute promyelocyte leukemia

In Human Hepatoma (HuH-7) cells – GAX caused immediate inhibition of DNA systhesis and activation of ERK and JNK mitogen-activated protein kinases.

In vitro – inhibate topoisomerases I and IIα

[26]
Ganoderic Acids T (GA-T) Human metastatic lung carcinoma (95-D)

Apoptosis induction and cell line arrest at G (1) phase

Induce cytotoxicity in human carcinoma cell lines in a dose-dependent manner, less toxic to normal human cell lines.

[27]

Anti-Allergic Property

The first line in the treatment of minor allergies are histamine H1 receptor antagonists. However, they respond poorly to acute hives or pruritic diseases [16]. Thus, studies to develop new adjuvant treatments based on G. lucidum extract against symptoms that are resistant to antihistamines are ongoing. Studies have shown that the properties of mushrooms from the Ganodermataceae family are able to restore the balance between TH1 and TH2 immune states [28]. In addition, there have been studies linking the potential of polysaccharides extracted from G. lucidum to the process of restoring IL-2 production that has been inhibited by the aging process observed in mice [29]. Powell studied the efficacy of unfractionated G. lucidum to determine the role of the medicinal fungus in managing the histamine-mediated immune response. The experiment took two males of different ages into the study. The first man aged 39, who had suffered from hay fever as a child, was initially given a dose of G. lucidum tablets of 3g per day (6 tablets x 500mg) with maintenance of this dose until symptoms subsided. The process of maintaining and decreasing the dose to 1. 5g per day (3 tablets x 500mg) showed a significant decrease in symptoms after 10 days of treatment. The second subject, a 5-year-old male who developed hay fever at the age of 4, was given an initial dose of 1g per day (2 tablets x 500mg) maintained until the end of the season. For the youngest subject, a 90% reduction in symptoms was achieved after one week. A review article, reported by Sanodiya et al. 2009 [6], synthesized studies showing inhibition of histamine release by mast cells from rat subjects, finding that ganoderic acids C and D, for the first time, played an important role in the inhibition of histamine release. Also, the compound cyclo-octasulfur found in G. lucidum composition inhibited the release of histamine from peritoneal mast cells of rat subjects, justified by membrane proteins interaction for inhibiting the Ca2+ uptake causing for the benefit, blockade of histamine release [18].

Anti-Bacterial and Anti-Viral Activity

There are many studies based on antiviral, antibacterial and antifungal treatment and they are aimed at discovering new herbal therapies. This approach is being considered due to patient neglect of anti-infectious therapies and the triggering of antibiotic resistance and adverse effects. The aim of these studies is to discover new factors that specifically inhibit antiviral and antibacterial activity without affecting the normal cell [30]. According to the literature, numerous experiments have been conducted to prove the efficacy of G. lucidum extract for further use as an antimicrobial or antiviral agent. Kim et al. [31], reported anti-herpetic activity of acidic protein bound polysaccharide, isolated from G. lucidum. The results showed potent antiviral activity against HSV-1 and HSV-2 [31]. Many studies have shown that antibacterial compounds in G. lucidum have inhibitory potential on gram-positive and gram-negative bacteria [32]. Both polysaccharide bioactive compounds and triterpenoids from G. lucidum have been shown to be effective in the antibacterial process [33]. Extracts provided from G. lucidum have been shown to exhibit antibiotic properties by inhibiting the growth of gram-positive and gram-negative bacteria [34]. Many studies reporting that these properties have been conducted mostly on Escherichia coli and Bacilus subtilis [32]. From the studies, different levels of antibiotic activity against Staphylococcus aureus, Salmonella sp. and Pseudomonas aeruginosa are observed [35]. Another study showed that G. lucidum extract inhibits Helicobacter pylori, responsible for gastric ulcer formation [32]. Different extracts of G. lucidum have also been studied, but the methanolic extract showed antimicrobial activity against Escherichia coli, Staphylococcus aureus and Pseudomonas aeruginosa [36].

Immuno-Modulatory and Antioxidant Property

According to Joseph et al. 2018 [3] study, chloroform extract of G. lucidum shows significant superoxide anion, nitric oxide, and lipid peroxidation inhibition activity. Following these tests, G. lucidum presents a source of interest for its natural antioxidant properties for the medical, pharmaceutical, and cosmetic industries.

A lot of research has focused on the immune-modulatory activity of G. lucidum, a lot of them have shown that its activity is mainly due to the presence of polysaccharides components, proteins, and triterpenoids [37]. An effect of the activation of immune response stimulating T cells, macrophages and natural killer cells was reported in a study that have been carried out on the subjects, mice [38]. The same result has been shown by Wong at al. 2004, too [39].

A study by Shi et al. 2013 [40], defined the antioxidant and immunoregulatory potential of Ganoderma extract, obtaining four types of polysaccharide compounds (GLP-I, GLP-II, GLP-III, GLP-IV). For the structural characterization of the compounds, Fourier transform infrared spectroscopy (FTIR) was used, and to determine the monosaccharide composition. This analysis showed that structurally the four identified compounds are similar, but the monosaccharides composition is significantly different. GLP-III and GLP-IV were found to be composed of six types of monosaccharides while GLP-II was found to be composed of three types. The results showed that all four types of polysaccharides performed antioxidant activity in a dose-dependent concentration, moreover, GLP-III and GLP-IV exhibited a significant scavenging effect on hydroxyl radicals, ABTS radicals and DPPH free radicals. The same study showed that 40 µg/mL of GLP, significantly stimulates macrophage proliferation and higher nitric oxide production [40].

Conclusions

Ganoderma lucidum is a traditional medicinal mushroom, appreciated for its many pharmacological effects and is increasingly consumed by the population to support a healthy life or as an adjuvant treatment in various acute or chronic diseases. Due to the numerous studies that have been carried out on both mice and humans, it can be concluded that the pharmacological effects of the medicinal mushroom are confirmed by the abundant presence of polysaccharides and triterpenoids, and in most studies, there was no evidence of renal or hepatic toxicity or changes in DNA genes [41]. However, there is a lack of studies on topical administration of G. lucidum extract and its possible pharmacological effects for epithelial regeneration as well as its anti-aging effect.

Bibliography

Taofiq, O., Heleno, S. A., Calhelha, R. C., Alves, M. J., Barros, L., Gonzales-Paramas, A. M., Berreiro, M. F., Ferreira, I. C. F. R. The potential of Ganoderma Lucidum extract as bioactive ingradients in topical formulations, beyond its nutritional benefits. Food and Chemical Toxicology 108:139-147, 2017

Wachtel-Galor, S., Yuen, J., Buswell, J. A., Benzie, F. F. I. Ganoderma Lucidum (Lingzhi or Reishi): A Medicinal Mushroom. Herbal Medicine: Biomolecular and Clinical Aspects. 2nd edition, 9, 2011

Joseph S., Sabulal, B., George, V., Smina, T. P., Janardhanan, K. K. Antioxidative and Antinflammatory Activities of the Chloroform Extract of Ganoderma lucidum Found in South India. Scienta Pharmaceutica 77:111-121, 2009

Sudheer, S., Alzorqi, I., Manickam, S., Ali, A. Bioactive Compounds of the Wonder Medicinal Mushroom “Ganoderma lucidum”. Merillon, JM., Ramawat, K. (eds) Bioactive molecules in food. Reference series in Phytochemistry, Springer, 2018

Barbieri, A., Quagliariello, V., Vecchio, V. D., Falco, M., Luciano, A., Amruthraj, N. J., Nasti, G., Ottaiano, A., Berretta, M., Iaffaioli, R. V., Arra, C. Anticancer and Anti-inflammatory Properties of Ganoderma lucidum Extract Effects on Melanoma and Triple-Negative Breast Cancer Treatment. Nutrients 9(3):210, 2017

Sanodiya, B., S., Thakur, G., S., Baghel, R., K., Prasad, G., B., Bisen, P., S. Ganoderma lucidum: a potent pharmacological macrofungus. Curr. Pharm. Biotechnol 10:717-742, 2009

Richter, C., Wittstein, K., Kirk, P. M., Stadler, M. An assessment of the taxonomy and chemotaxonomy of Ganoderma. Fungal Diversity 71(1):1-5, 2015

Cheng, J., Lin, C. S., Lu, C. C., Martel, J., Ko, Y. F., Ojcius, D. M., Tseng, S. F., Wu, T. R., Chen, Y. Y., Young, J. D., Lai, H. C. Corrigendum: Ganoderma lucidum reduces obesity in mice by modulating the composition of the gout microbiota. Nature Communications 8:16130, 2017

Boh, B., Berovic, M., Zhang, J., Zin-Bin, L. Ganoderma luicdum and its pharmaceutically active compounds. Biotechnol Annu. Rev. 13:265-301, 2007

Pascale, C., Sirbu, R., Cadar, E. Importance of Bioactive Compounds of Ganoderma lucidum Extract in Medical Field. European Journal of Natural Science and Medicine 5(1): 39-47, 2022

Dragan, A-M-L., Sirbu, R., Cadar, E. Valuable Bioactive Compounds Extracted from Ceramium rubrum on the Romanian Seaside with Medical Interest. European Journal of Natural Science and Medicine 5(1): 63-73, 2022

Cor, D., Knez, Z., Hrencic, M. K. Antitumour, Antimicrobial, Antioxidant and Antiacetylcholinesterase Effect of Ganoderma Lucidum Terpenoids and Polysaccharides: A Review. Molescules 13(23): 649, 2018

Bhat, Z. A., Wani, A. H., War, J. M., Bhat, M. Y. Major Bioactive Properties of Ganoderma lucidum Polysaccharides: A review. Asian Journal of Pharmaceutical and Clinical Research. 14(3): 11-24, 2021

Choong, Y-K., Ellan, K., Chen, X-D., Mohamad, S. A. Extraction and Fractionation of Polysaccharides from a Selected Mushroom Species, Genoderma lucidum: A Critical Review. Fractionation. doi: 10.5772/intechopen.78047, 2019

Ma, H-T., Hsieh, J-F., Chen, S-T. Anti-diabetic effects of Ganoderma lucidum. Phytochemistry 114:109-113, 2015

Smith, J., Rowan, N., Sullivan, R. Medicinal Mushrooms: Their Therapeutic Properties and Current Medical Usage with Special Emphasis on Cancer Treatment. Special Report Commissioned by Cancer Research UK, the University of Strathclyde, p. 256, 2022

Chang, S. T., Wasser, S. P. The role of culinary-medicinal mushrooms on human welfare with a pyramid model for human health. Int. J. Med. Mushrooms 14(2): 95-134, 2014

Zhou, S. H., Gao, Y. The immunomodulating effects of Ganoderma lucidum (Curt: Fr.) P. Karst. (Ling Zhi, Reishi mushroom) (Aphyllophoromycetideae). Int. J. Med. Mushrooms 4(1): 1-11, 2002

Veljovic, S., Veljovic, M., Nikicevic, N., Despotovic, S., Radulovic, S., Niksic, M., Filipovic, L. Chemical composition, antiproliferative and antioxidant activity of differently processed Ganoderma lucidum ethanol extracts. J. Food Sci. Technol. 54(5):1312-1320, 2017

Kolniac- Ostek, J., Oszmianski, J., Szyjka, A., Moreira, H., Barg, E. Anticancer and Antioxidant Activities in Ganoderma lucidum Wild Mushrooms in Polland, as Well as Their Phenolic and Triterpenoid Compounds. International Journal of Molecular Science 23:9359, 2022

Silva, D. Ganoderma lucidum (Reishi) in cancer treatment. Integr. Cancer Ther. 2(4): 358-62, 2003

Silva, D., Labarrere, C., Silvova, V., Sedlak, M., Lloyd, F. P., Ho, N. W. Y. Ganoderma lucidum suppresses motility of highly invasive breast and prostate cancer cells. Biochemical and Biophysical Research Communications 298: 603-612, 2002

Sadava, D., Still, D. W., Mudry, R. R., Kane, S. E. Effect of Ganoderma on drug-sensitive and multidrug-resistant small-cell lung carcinomas cells. Cancer lett. 277(2): 189-2, 2009

Lu, Q-Y., Jin, Y-S., Zhang, Q., Zhang, Z., Heber, D., Go, V. L. W. Ganoderma lucidum extracts inhibit growth and induce actin polymerization in bladder cancer cells in vitro. Cancer lett. 216(1): 9-20; 2004

Muller, C. I., Kumagai, T., O’Kelly, J., Seeram, N. P., Heber, D., Koeffler, P. Ganoderma lucidum causes apoptosis in leukemia, lymphoma and multiple myeloma cells. Leukemia Research 30(7): 841-848, 2006

Li, C-H., Chen, P-Y., Chang, U-M., Kan, L-S., Fang, W-H., Tsai, K-S., Lin, S-B. Ganoderic acid X, a lanostanoid triterpene, inhibits topoisomerases and induces apoptosis of cancer cells. Life Sci. 77(3): 252-65, 2005

Tang, W., Liu, J-W., Zhao, W-M., wei, D-Z., Zhong, J-J. Ganoderic acid T from Ganoderma lucidum mycelia induces mithochondria mediated apoptosis in lung cancer cells. Life Sci. 80(3): 205-11, 2006

Andough, T., Zhang, Q., Yamamoto, T., Tayama, M., Hattori, M., Kuraishi, Y. Inhibitory Effects of the Methanol Extracts of Ganoderma lucidum on Mosquito Allergy-Induced Inch-Associated Responses in Mice. Journal of Pharmacological Science 114: 292-297, 2010

Powell, M. The Use of Ganoderma lucidum in: The Management of Histamine-Mediated Allergic Responses. Townsend Letter for Doctors and Patients (Collin, J. and Brown L. Ed.), p. 26-30, 2006

Zhong, J. J., Xiao, J. H. Secondary metabolites from higher fungi: discovery, bioactivity and bioproduction. Adv. Biochem. Eng. Biotechnol. 113:79-150, 2009

Kim, Y.S, Seong-Kug, E., Ki-Wan, O. Chong-kil, L., Seong-Sun, H. Antiherpetic activities of acidic protein bound polysaccharide isolated from Ganoderma lucidum alone and in combinations with interferons. Journal Ethnopharmacology 72: 451-458, 2000

Suay, I., Arenal, F., Asensio, F. J., Basilio, A., Cabello, M. A., Diez, M. T., Garcia, J. B., del Val, A. G., Corrochategui, J., Hernandez, P., Pelaez, F., Vicente, M. F. Screening of Basidiomycetes for antimicrobial activities. Antonie Van Leeukenhoek 78: 129-139, 2000

Smania, E. F. A., Monache, F. D., Yunes, R. A., Paulert, R., Smania Jr., A. Antimicrobial activity of methyl australate from Ganoderma tsugae. Brasilian Journal of Pharmacognosy 17(1): 14-16, 2007

Gao, Y., Zhou, S. H., Huang, M., Xu, A. Antibacterial and antiviral value of the genus Ganoderma P. Karst. species (Aphyllophoromycetideae: arevies. Int. J. Med. Mushroom 5(3): 235-246, 2003

Sheena, N., Ajith, T. A., Mathew, A., Jadardhanan, K. K. Antibacterial Activity of Three Macrofungi, Ganoderma lucidum, Navesporus floccose and Phellinus rimosus Occurring in South India. Pharmaceutical Biology 41(8): 564-567, 2003

Gaylan, C. M., Estebal, J. C., Tantengco, O. A. G., Ragragio, E. M. Anti-Staphylococcal and Antioxidant Properties of Crude Ethanolic Extracts of Macrofungi Collected from the Philippines. Pharmacogn. J. 10(1):106-109, 2018

Gao, Y. Zhou, S., Jiang, W., Huang, M., Dai, X. Effects of Ganopoly (A Ganoderma lucidum Polysaccharide Extract) on the Immune Functions in Advanced-Stage Cancer Patients. Immunological investigations 32(3): 201-215, 2003

Wang, P. Y., Zhu, X. L., Lin, Z. B. Antitumor and immunomodulatory effects of polysaccharides from broken-spore of Ganoderma lucidum. Frontiers in pharmacology 3: 135, 2012

Wong, K. L., Chao, H-H., Chan, P., Chang L-P, Liu, C-F. Antioxidant activity of Ganoderma lucidum in acute ethanol-induced heart toxicity. Phytother. Res. 18(12):1024-6, 2004

Min, S., Zhang, Z., Yang, Y. Antioxidant and immunoregulatory activity of Ganoderma lucidum polysaccharide (GLP). Carbohydrate Polymers 95(1): 200-206, 2013

Wachtel-Galor, S., Tomlinson, B., Benzie, I. F. F. Ganoderma lucidum (“Lingzhi”), a Chinese medicinal mushroom: biomarker responses in a controlled human supplementation study. Br. J. Nutr 91(2):263-9, 2004


© 2025 The Author(s). Published by Mentisia under CC BY-NC-SA 4.0.